catalog number :
MBS2047537
products full name :
HRP-Linked Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
products short name :
[Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)]
products name syn :
[P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1]
other names :
[cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A]
products gene name :
[CDKN2A]
other gene names :
[CDKN2A; p16]
purity :
Antigen-specific Affinity Chromatography
form :
Supplied as solution form in 0.01M PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
concentration :
0.76 mg/ml
storage stability :
Storage: Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
tested application :
Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).
app notes :
Western blotting: 0.5-2 ug/mL;1:380-1500. Immunohistochemistry: 5-20 ug/mL;1:38-150. Immunocytochemistry: 5-20 ug/mL;1:38-150.
Optimal working dilutions must be determined by end user
other info1 :
Organism Species: Homo sapiens (Human). Source: Antibody labeling. Label: HRP. Traits: Liquid. Immunogen: Recombinant CDKN2A (Ser8~Asp156) expressed in E.coli
other info2 :
Unconjugated Antibody: The unconjugated antibody version of this item is also available as catalog #MBS2013669
ncbi acc num :
NP_001277177.1
ncbi gb acc num :
NM_001290248.1
ncbi pathways :
Bladder Cancer Pathway (741851); Bladder Cancer Pathway (527); Cell Cycle Pathway (741726); Cell Cycle Pathway (463); Chronic Myeloid Leukemia Pathway (741853); Chronic Myeloid Leukemia Pathway (528); Endocrine Resistance Pathway (1404388); Endocrine Resistance Pathway (1402111); Glioma Pathway (741847); Glioma Pathway (522)